RxDoctor Payments Data

Leanne Schimke

Family · Lancaster, PANPI 1194722678

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.6%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Bayer at 34.9% of the total. Reporting peaked in 2022 at $3,884 and has fallen 99.2% since, to $32 in 2024. Among family clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,721in general payments, 2019–2025

Across 164 payments — averaging $47.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$3K
  • Pfizer$1K
  • Dendreon Pharmaceuticals LLC$1K
  • Hollister Incorporated$768
  • Johnson & Johnson$334
  • Urovant Sciences Inc$308
  • plus $1K from 21 others

What the payments were for

  • Speaking & faculty fees$4,21355%
  • Food & beverage$3,30943%
  • Education$1993%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,721 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania →

Other family in Lancaster

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →